Evidence map›Paper›PMID 41696711›Full record

ArticleJAC-antimicrobial resistance2026

Fatoumata Ousmane Maiga, Laurent Dembele, Souleymane Dama, Ousmaila Diakite, Fatoumata Diallo, Fanta Sogore, Mohamed Maiga, François Dao, Niawanlou Dara, Mohamed Lamine Alhousseini and 2 more

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fatoumata Ousmane MaigaUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.ORCID https://orcid.org/0000-0002-5672-2307
Laurent DembeleUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.ORCID https://orcid.org/0000-0001-9087-8439
Souleymane DamaUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Ousmaila DiakiteUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Fatoumata DialloUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Fanta SogoreUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Mohamed MaigaUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
François DaoUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Niawanlou DaraUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Mohamed Lamine AlhousseiniUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Oumar Bila TraoreUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.
Abdoulaye A DjimdeUniversity of Sciences, Techniques, and Technologies of Bamako (USTTB), Faculty of Pharmacy, Parasites and Microbes Research and Training Center (P-MRTC), Point G. PBE: 1805, Bamako, Mali.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives: The emergence and spread of antimalarial drug resistance threaten malaria control efforts in sub-Saharan Africa. Monitoring the susceptibility of circulating Methods: Twenty-six isolates collected from patients with uncomplicated malaria at three endemic sites (Faladje, Kolle and Bougoula-Hameau) were cultured Results: Tafenoquine showed a very low potency (IC Conclusions: While current frontline therapies remain effective, reduced activity of chemopreventive antimalarials supports the need for continued surveillance to detect early signs of resistance in Mali. The potent activity of next-generation candidates (cabamiquine and GNF179) supports their potential for further clinical development and field deployment.

Identifiers

PMID41696711
PMCPMC12895194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.